INS and acromegaly: Lowering GH levels improves glycemic control and increases insulin sensitivity in acromegaly; however, SRL therapy may exert variable effects on glucose metabolism, with worsening due to inhibition of insulin secretion and improvement due to improved insulin sensitivity with acromegaly control [39, 40].